CBD Bioavailability by Delivery Method: Vapes vs Tinctures vs Gummies

What Is Bioavailability, and Why Does It Matter?

Bioavailability is the proportion of a substance that reaches your systemic circulation (your bloodstream, in other words) in an active, unchanged form. It’s expressed as a percentage. A drug given intravenously has 100% bioavailability by definition, because it goes directly into the blood. (For THC, see why edibles, vapes and tinctures hit differently.) Every other route of administration (oral, inhaled, sublingual, topical) delivers less than 100% and the exact percentage depends on how much of the dose gets absorbed and how much survives the trip.

For CBD, bioavailability matters in two concrete ways:

1. Label dose is not body dose. A 25mg gummy does not give your body 25mg of CBD. On an empty stomach it gives you an estimated 1 to 2mg, and more with a fatty meal. Dosing calculations that treat the label number as the blood level are wrong
2. Products at the same label dose feel different. Two 25mg CBD products with different delivery methods can produce noticeably different subjective effects because one delivers five times more active CBD to your blood than the other

The primary academic reference for this entire topic is a 2018 systematic review by Millar, Stone, Yates, and O’Sullivan in Frontiers in Pharmacology (Volume 9, Article 1365). They analyzed 24 pharmacokinetic studies of CBD in humans and documented half-life ranges and peak plasma concentrations across multiple routes. Only one study it found measured absolute bioavailability, and that was for smoked CBD. It’s the canonical citation most other CBD articles should (and don’t always) point to.

The First-Pass Metabolism Problem

Before we break down each delivery method, one piece of physiology makes the whole picture make sense: the liver’s first-pass metabolism.

When you swallow a CBD gummy, the CBD goes through your stomach, gets absorbed in the small intestine, and enters your portal venous blood. That blood drains directly into your liver before it reaches the rest of your body. In the liver, a family of enzymes called cytochrome P450 (primarily CYP2C19 and CYP3A4 for CBD) metabolize a large portion of the CBD before it can leave the liver and enter systemic circulation. That’s first-pass metabolism. It’s the same process that makes oral delta-9 THC edibles take so long to hit, and the same process that creates the 11-hydroxy-THC metabolite that makes edibles feel different from smoked cannabis.

First-pass metabolism is why oral CBD has such low bioavailability. Most of the CBD never gets to your blood intact. Routes that bypass the digestive tract (inhalation, sublingual, topical, transdermal) skip the first-pass and deliver more CBD to circulation per milligram consumed. That’s the single biggest variable behind why different delivery methods produce such different effective doses.

Method 1: Inhalation (Vapes and Smoking)

Bioavailability: about 31% (estimate)
Onset: 2 to 10 minutes
Duration: 2 to 3 hours

Inhalation is the highest-bioavailability delivery method by a wide margin. When you inhale CBD vapor or smoke, the CBD crosses from the alveoli in your lungs directly into your pulmonary capillaries, then into your heart, and from there to the rest of your body within seconds. There’s no first-pass metabolism because the blood leaving the lungs doesn’t go through the liver first.

That estimate comes from a small 1986 study in which five people smoked CBD. On average about 31% reached the bloodstream, with a four-fold spread between people (Ohlsson 1986). Vaping hasn’t been measured the same way in people, so treat any vape number as an estimate. McGilveray’s 2005 pharmacokinetic review in Pain Research and Management reported similar patterns for inhaled cannabinoids more broadly, with smoked THC averaging around 30% bioavailability and considerable inter-individual variation.

Inhalation is the method of choice when you need fast onset. Most people feel effects within 5 to 10 minutes, and you can titrate dose in real time by taking additional puffs. The trade-off is duration: the effects fade relatively quickly, typically within 2 to 3 hours for a single session.

Health context for inhalation

Smoking any plant material exposes your lungs to combustion byproducts, including tar and polycyclic aromatic hydrocarbons. Vaping CBD oil avoids most combustion but introduces its own considerations (thinning agents, heating-element compatibility, device quality). If you’re using inhaled CBD regularly, look for vape formulations with no thinning agents such as propylene glycol. Our CBD vape cartridge collection is built for this reason.

Method 2: Sublingual (Tinctures and Oils)

Bioavailability: no reliable human number yet (likely between oral and inhaled)
Onset: 15 to 45 minutes
Duration: 4 to 6 hours

Sublingual administration is the middle ground between inhalation and oral. When you hold a CBD tincture under your tongue for 60 to 90 seconds before swallowing, some of the CBD absorbs through the highly vascularized mucous membranes in your mouth and enters systemic circulation directly, bypassing the liver. There’s no reliable human bioavailability number for sublingual CBD yet. It’s likely somewhere between oral and inhaled, depending on how long you hold it.

The catch: most people don’t actually use tinctures sublingually. They drop the oil on their tongue, swallow immediately, and effectively convert the tincture into an oral dose. If you want the sublingual bioavailability advantage, you have to hold it under the tongue. The longer you hold it (up to about 90 seconds), the more absorbs through the oral mucosa. Whatever isn’t absorbed sublingually gets swallowed and enters the normal oral pathway, so you get a mix of both routes.

Tinctures are the most flexible dosing format. You can measure single-milligram precision using the dropper, adjust up or down easily, and get a middle-ground onset that’s faster than gummies but not as immediate as vaping. The primary downsides are the hemp taste (mitigated with flavored formulations) and the discipline required to actually hold the dose under the tongue.

MCT oil and absorption

Most CBD tinctures use MCT (medium-chain triglyceride) oil as a carrier. MCT is chosen because it’s well-tolerated, flavor-neutral, and may slightly improve CBD absorption by keeping the lipophilic CBD molecule dissolved and bioavailable to mucosal tissue. The research on MCT versus other carrier oils for CBD specifically is limited, but MCT is the standard for practical reasons.

Method 3: Oral (Gummies, Capsules, Beverages)

Bioavailability: about 6% on an empty stomach (estimate)
Onset: 30 to 120 minutes
Duration: 4 to 8 hours

Oral CBD is the most consumed form because it’s the most convenient (no holding, no inhaling, just chew and swallow). It’s also the lowest-bioavailability method because it runs headlong into the first-pass metabolism problem described above. Most of the CBD you swallow either doesn’t get absorbed from the gut or gets metabolized in the liver before reaching systemic circulation. A 2020 review estimated oral bioavailability at about 6% on an empty stomach, rising roughly fourfold with a high-fat meal (Perucca and Bialer 2020). No human study has measured it directly yet, so treat that number as an estimate.

Absorption varies a lot because several variables affect it:

• Formulation matters. A gummy with the CBD simply mixed into the base has lower bioavailability than a gummy where the CBD is formulated with emulsifiers or in a lipid carrier
• Food effect is large. Consuming CBD with a high-fat meal can substantially increase absorption, sometimes more than doubling total exposure compared to a fasted state
• Individual CYP enzyme activity varies. People with slower CYP2C19 or CYP3A4 activity clear less CBD during first-pass, which raises their effective bioavailability

Oral CBD has the longest duration of the common methods. Because absorption is slow and metabolism is gradual, effects typically last 4 to 8 hours or more. That’s part of the appeal for evening use or sustained-throughout-the-day dosing.

Method 4: Topical (Creams and Lotions)

Systemic bioavailability: less than 1%
Local onset: 15 to 60 minutes
Local duration: varies, typically hours

Topical CBD is a different category. Standard creams, lotions, salves, and balms are not designed to deliver systemic CBD. They’re designed to deliver localized effect at the application site, where the CBD interacts with cannabinoid receptors in the skin and superficial tissues.

CBD is strongly lipophilic (fat-soluble) with a log-p in the 6 to 7 range, which means it doesn’t cross the aqueous outer layer of skin easily. Standard topical formulations tend to keep the CBD in the stratum corneum and underlying layers without reaching the bloodstream. That’s fine if your goal is localized effect (muscle soreness, joint discomfort, skin-level support) but it’s the wrong delivery method if you’re trying to influence the whole body.

If a topical advertises “systemic bioavailability,” that’s a red flag unless the product is a specialized transdermal system (next section). Standard creams are local-only by design.

Method 5: Transdermal (Patches)

Systemic bioavailability: variable, product-specific
Onset: slow, gradual
Tmax (time to peak blood level): about 8 hours in one study (2.5 to 12 hours)

Transdermal patches are distinct from standard topicals. They’re formulated with permeation enhancers (often ethanol, oleic acid, or proprietary delivery systems) specifically designed to push cannabinoids through the skin barrier and into systemic circulation. A 2023 study of a novel transdermal CBD/THC system in Advances in Therapy (Varadi et al.) found CBD peaked in the blood about 8 hours after application (range 2.5 to 12 hours), with low peak levels and no psychoactive effects reported.

The practical use case for transdermal CBD is prolonged, consistent dosing without peaks and valleys. You apply the patch, it delivers cannabinoids into your bloodstream over many hours, and you get a flatter pharmacokinetic curve than any oral or inhaled dose could produce. The trade-off: slow onset and the product-quality question (well-designed patches are expensive and uncommon; poorly designed patches function more like topicals).

Side-by-Side Method Comparison

Factors That Change Your Personal Bioavailability

The percentages above are rough estimates from a handful of small studies. Your individual bioavailability on any given dose depends on several variables.

• Food, especially fat content. A high-fat meal can substantially increase oral CBD absorption. For oral CBD you actually want to eat something fatty, the opposite of what you’d do with most medications
• Body composition. CBD is lipophilic and distributes into fat tissue. Higher body fat percentage means more of the absorbed CBD gets sequestered into adipose storage rather than circulating to receptors
• Liver enzyme activity. CYP2C19 and CYP3A4 variability (genetic and drug-induced) changes how much first-pass metabolism removes before the CBD reaches circulation
• Drug interactions. CBD inhibits several of these enzymes itself (including CYP3A4, CYP2C9 and CYP2C19), which can raise blood levels of medications that use those enzymes. That same inhibition, applied to CBD’s own metabolism, means co-administration with certain drugs can raise CBD’s effective bioavailability
• Inhalation technique. Deep, slow inhalation with 3 to 5 second breath-hold maximizes alveolar absorption. Shallow, fast puffs deliver less
• Formulation quality. Nanoemulsions, liposomes, and self-emulsifying drug delivery systems can improve oral bioavailability. So can MCT-based carrier oils in tinctures. Product formulation matters as much as route

The practical implication: if you’re trying to compare products or figure out what dose you actually need, treat the label number as a starting point and adjust based on what you observe, not what you expect.

Dose Equivalence Across Methods

How do you translate a dose from one method to another? There isn’t a clinical-grade answer, but you can make reasonable approximations using the estimates above.

These are rough approximations. Individual bioavailability varies enough that the same label dose could produce four-fold differences between two people using the same method. Use this as a directional tool, not a formula.

Which Method for Which Goal?

Different situations favor different delivery methods. A practical breakdown.

Choose inhalation (vape or flower) if:

• You need fast relief (less than 10 minutes to onset)
• You want to titrate dose in real time by taking additional puffs
• You’re dealing with an acute situation and don’t want to wait 90 minutes
• You’re okay with a shorter effect window (2 to 3 hours)
• You have healthy lungs and you’re comfortable with the respiratory route

Choose sublingual (tincture) if:

• You want the bioavailability advantage without inhaling
• You need precise, adjustable dosing (single-milligram increments)
• You’re comfortable with a 15 to 45 minute onset
• You want a middle-ground duration (4 to 6 hours)
• You can commit to holding the oil under your tongue for 60 to 90 seconds

Choose oral (gummy, capsule, beverage) if:

• You want the longest duration of any common method (4 to 8+ hours)
• You prefer the convenience and taste of a food-like product
• Slow onset is acceptable for your use case (evening wind-down, sustained dosing)
• You’re willing to dose higher to compensate for lower bioavailability
• You’ll take it with a fatty meal to improve absorption

Choose topical if:

• Your goal is localized effect (specific muscle, joint, or skin area)
• You don’t want any systemic CBD in your bloodstream
• You’re layering with another method for combined systemic + local approach
• Drug testing is a concern and you want to minimize systemic absorption risk

A Note on Nanoemulsions and “Enhanced” Bioavailability

Nanoemulsion CBD products (and adjacent technologies: liposomal CBD, water-soluble CBD, self-emulsifying drug delivery systems) are designed to improve the bioavailability of oral CBD by creating ultra-small droplets of CBD that disperse in water and are more easily absorbed from the gut.

The idea is sound. Properly formulated nanoemulsions can raise oral absorption in some studies, though how much varies from product to product.

The challenge is verification. Most products labeled “nanoemulsion” or “water-soluble” aren’t independently tested for actual particle size or actual human bioavailability. Marketing claims run far ahead of the science for specific products. If a product is selling on “enhanced bioavailability,” look for:

• Particle size disclosure (true nanoemulsions are typically <200 nm)
• Independent pharmacokinetic testing results (not manufacturer claims)
• Third-party lab confirmation of formulation integrity
• Certificate of analysis showing the actual CBD content matches the label

Our guide on reading certificates of analysis walks through what to look for when evaluating any claimed formulation advantage.